A Global, Multicenter, Randomized, Open-label, Phase 3 study of Sacituzumab Govitecan versus Standard of Care (SoC) in Previously Treated Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Phase

Phase III Clinical Trial

Trial Number

06801834

Trial Status

OPEN